Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Surufatinib |
Trade Name | |
Synonyms | Sulfatinib|HMPL-012 |
Drug Descriptions |
Surufatinib (HMPL-012) is a dual VEGFR/FGFR1 inhibitor, which inhibits tumor growth (AACR; Mol Cancer Ther 2015;14(12 Suppl 2):Abstract nr A1, PMID: 30880071). |
DrugClasses | FGFR1 Inhibitor 26 VEGFR Inhibitor (Pan) 33 |
CAS Registry Number | 1308672-74-3 |
NCIT ID | C116066 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + Surufatinib | Gemcitabine Surufatinib | 0 | 1 |
Surufatinib | Surufatinib | 0 | 3 |
Surufatinib + Tislelizumab | Surufatinib Tislelizumab | 0 | 1 |